The business agency reported on January 8 that an authoritative person disclosed to the China Securities Journal reporter on the 6th that the relevant departments planned to invest RMB 40 billion in the major new drug R&D and creation fields for the biomedical industry during the “Twelfth Five-Year Plan†period. Five times more than doubled. In the specific areas of support, the support for research and development of biological products has increased significantly.
Of this total of 40 billion yuan in special funds, the central government allocated 10 billion yuan, and the remaining funds for the local governments at all levels and enterprises to raise funds. The special funds allocated to the same field during the “Eleventh Five-Year Plan†period was 17.8 billion yuan.
Authoritative sources revealed that the upcoming "12th Five-Year Plan" of the biomedical industry highlights the support for the R&D and industrialization of biological products, and proposes to strive to realize the industrialization of more than 10 biotech drugs with independent intellectual property rights by 2015. engineering.
According to the "12th Five-Year Plan" of the biomedical industry, pharmaceutical companies that have made breakthroughs in the research, development, process improvement, technological innovation, and large-scale production of essential drugs are expected to receive special financial support.
The field of biological products includes genetic engineering, cell engineering, enzyme engineering, and the like. In order to achieve the above goals, China will issue special support policies related to the research and development of biological products, such as the transformation of traditional medicines with bio-pharmaceutical technology and the substitution of chemical drugs with enzymatic alternatives.
At present, there are more than 200 pharmaceutical companies in China that are engaged in research, development and production of biological products. However, biological products account for only about 10% of the total pharmaceutical production value. Experts predict that with the "plus" of policy support, biological products are expected to achieve major R&D breakthroughs during the "12th Five-Year Plan" period.
Of this total of 40 billion yuan in special funds, the central government allocated 10 billion yuan, and the remaining funds for the local governments at all levels and enterprises to raise funds. The special funds allocated to the same field during the “Eleventh Five-Year Plan†period was 17.8 billion yuan.
Authoritative sources revealed that the upcoming "12th Five-Year Plan" of the biomedical industry highlights the support for the R&D and industrialization of biological products, and proposes to strive to realize the industrialization of more than 10 biotech drugs with independent intellectual property rights by 2015. engineering.
According to the "12th Five-Year Plan" of the biomedical industry, pharmaceutical companies that have made breakthroughs in the research, development, process improvement, technological innovation, and large-scale production of essential drugs are expected to receive special financial support.
The field of biological products includes genetic engineering, cell engineering, enzyme engineering, and the like. In order to achieve the above goals, China will issue special support policies related to the research and development of biological products, such as the transformation of traditional medicines with bio-pharmaceutical technology and the substitution of chemical drugs with enzymatic alternatives.
At present, there are more than 200 pharmaceutical companies in China that are engaged in research, development and production of biological products. However, biological products account for only about 10% of the total pharmaceutical production value. Experts predict that with the "plus" of policy support, biological products are expected to achieve major R&D breakthroughs during the "12th Five-Year Plan" period.
Medical protective glasses,Anti-epidemic medical goggles,Isolated medical goggles,Quality medical protective glasses
Hebei Abiding Co.Ltd , https://www.hebeiabiding.com